Several studies have reported that oxidative stress and reactive oxygen species (ROS) downregulate SLC6A6 [19,36,37,38], while ROS levels are increased in atherosclerosis, vascular injury [39], and VSMCs treated with PDGF-BB (Figure S1). This evidence concerns the gene SLC6A6 and atherosclerosis.